Jun Lü
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 12
- Oncology 62
- Lung Cancer Research Studies 18
- Pancreatic and Hepatic Oncology Research 17
- Cancer Immunotherapy and Biomarkers 15
- Co-authors
- Baohui Han (48 shared papers)Bolun Jiang (13 shared papers)Junchao Guo (18 shared papers)Li Zhou (18 shared papers)Yizhi Wang (9 shared papers)Xiaodong Zhao (12 shared papers)Shun Ke (2 shared papers)Fankai Meng (2 shared papers)
- Journals
- Frontiers in Oncology (12 papers)Cell Death and Disease (8 papers)Frontiers in Immunology (6 papers)Cancer Letters (4 papers)Cancer Cell International (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jun Lü
176 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 777
- Oncology 664
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 439
- Hepatology 78
Countries citing papers authored by Jun Lü
This map shows the geographic impact of Jun Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Lü more than expected).
Fields of papers citing papers by Jun Lü
This network shows the impact of papers produced by Jun Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Lü. The network helps show where Jun Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 168 | |
| 2 | 2014 | 85 | |
| 3 | 2020 | 75 | |
| 4 | CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion. | 2015 | 73 |
| 5 | 2001 | 71 | |
| 6 | 2018 | 68 | |
| 7 | 2018 | 67 | |
| 8 | 2019 | 67 | |
| 9 | 2016 | 56 | |
| 10 | 2019 | 49 | |
| 11 | 2020 | 45 | |
| 12 | 2021 | 44 | |
| 13 | 2011 | 44 | |
| 14 | 2019 | 43 | |
| 15 | 2019 | 41 | |
| 16 | 2020 | 40 | |
| 17 | 2016 | 39 | |
| 18 | 2023 | 37 | |
| 19 | 2015 | 37 | |
| 20 | 2020 | 36 |
About Jun Lü
Jun Lü is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 187 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (18 papers), Pancreatic and Hepatic Oncology Research (17 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Immunotherapy and Biomarkers (15 papers), RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Cancer Research (777 citations), Oncology (664 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (439 citations) and Hepatology (78 citations). Jun Lü has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Baohui Han, Bolun Jiang, Junchao Guo, Li Zhou, Yizhi Wang, Xiaodong Zhao, Shun Ke, Fankai Meng, Ruichao Li and Minghao Fang. Their work appears in journals such as Frontiers in Oncology, Cell Death and Disease, Frontiers in Immunology, Cancer Letters and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.